Viola M.J. Verhoef

1.7k total citations · 1 hit paper
14 papers, 1.3k citations indexed

About

Viola M.J. Verhoef is a scholar working on Epidemiology, Oncology and Microbiology. According to data from OpenAlex, Viola M.J. Verhoef has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 6 papers in Oncology and 6 papers in Microbiology. Recurrent topics in Viola M.J. Verhoef's work include Cervical Cancer and HPV Research (13 papers), Global Cancer Incidence and Screening (6 papers) and Reproductive tract infections research (6 papers). Viola M.J. Verhoef is often cited by papers focused on Cervical Cancer and HPV Research (13 papers), Global Cancer Incidence and Screening (6 papers) and Reproductive tract infections research (6 papers). Viola M.J. Verhoef collaborates with scholars based in Netherlands, United States and Italy. Viola M.J. Verhoef's co-authors include Peter J.F. Snijders, Rita Banzi, Silvia Minozzi, Chris J.L.M. Meijer, Daniëlle A.M. Heideman, Folkert J. van Kemenade, Ruud L.M. Bekkers, Leon F.A.G. Massuger, Eero Suonio and Freija Verdoodt and has published in prestigious journals such as The Lancet Oncology, American Journal Of Pathology and British Journal of Cancer.

In The Last Decade

Viola M.J. Verhoef

14 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

2014 507 citations Marc Arbyn, Freija Verdoodt et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Viola M.J. Verhoef

Since Specialization

Citations

This map shows the geographic impact of Viola M.J. Verhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viola M.J. Verhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viola M.J. Verhoef more than expected).

Fields of papers citing papers by Viola M.J. Verhoef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viola M.J. Verhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viola M.J. Verhoef. The network helps show where Viola M.J. Verhoef may publish in the future.

Co-authorship network of co-authors of Viola M.J. Verhoef

This figure shows the co-authorship network connecting the top 25 collaborators of Viola M.J. Verhoef. A scholar is included among the top collaborators of Viola M.J. Verhoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viola M.J. Verhoef. Viola M.J. Verhoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study 2023 ·The Lancet Oncology ·(unknown), (unknown), (unknown), Viola M.J. Verhoef, Karolina Sikorska, Albert G. Siebers, Hans H.B. Wenzel, Maaike C.G. Bleeker, Eva Maria Roes, Ronald P. Zweemer, Peggy J. de Vos van Steenwijk, Refika Yigit, Jogchum Beltman, Petra L.M. Zusterzeel, Christianne Lok, Ruud L.M. Bekkers, Constantijne H. Mom, Nienke E. van Trommel	4
2	Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women 2017 ·Modern Pathology ·Renée M.F. Ebisch, (unknown), Meyke Hermsen, (unknown), Judith E. M. Vedder, Johan Bulten, Remko P. Bosgraaf, Viola M.J. Verhoef, Daniëlle A.M. Heideman, Peter J.F. Snijders, Chris J.L.M. Meijer, Folkert J. van Kemenade, Leon F.A.G. Massuger, Willem J. G. Melchers, Ruud L.M. Bekkers, Albert G. Siebers	47
3	Validation of the FAM19A4 / mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women 2016 ·Gynecologic Oncology ·Lise M.A. De Strooper, Viola M.J. Verhoef, Johannes Berkhof, Albertus T. Hesselink, (unknown), Folkert J. van Kemenade, Remko P. Bosgraaf, Ruud L.M. Bekkers, Leon F.A.G. Massuger, Willem J. G. Melchers, Renske D.M. Steenbergen, Peter J.F. Snijders, Chris J.L.M. Meijer, Daniëlle A.M. Heideman	85
4	The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples 2016 ·International Journal of Cancer ·Renée M.F. Ebisch, (unknown), Remko P. Bosgraaf, Leon F.A.G. Massuger, Joanna IntHout, Viola M.J. Verhoef, Daniëlle A.M. Heideman, Peter J.F. Snijders, Chris J.L.M. Meijer, Folkert J. van Kemenade, Johan Bulten, Albert G. Siebers, Ruud L.M. Bekkers, Willem J. G. Melchers	24
5	Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes 2015 ·Gynecologic Oncology ·Viola M.J. Verhoef, Folkert J. van Kemenade, Lawrence Rozendaal, Daniëlle A.M. Heideman, Remko P. Bosgraaf, Albertus T. Hesselink, Willem J. G. Melchers, Leon F.A.G. Massuger, Ruud L.M. Bekkers, Renske D.M. Steenbergen, Johannes Berkhof, Peter J.F. Snijders, Chris J.L.M. Meijer	23
6	Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis breakdown → 2014 ·The Lancet Oncology ·Marc Arbyn, Freija Verdoodt, Peter J.F. Snijders, Viola M.J. Verhoef, Eero Suonio, Lena Dillner, Silvia Minozzi, Cristina Bellisario, Rita Banzi, Fanghui Zhao, Peter Hillemanns, Ahti Anttila	507
7	Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial 2014 ·The Lancet Oncology ·Viola M.J. Verhoef, Remko P. Bosgraaf, Folkert J. van Kemenade, Lawrence Rozendaal, Daniëlle A.M. Heideman, Albertus T. Hesselink, Ruud L.M. Bekkers, Renske D.M. Steenbergen, Leon F.A.G. Massuger, Willem J. G. Melchers, Johan Bulten, Lucy Overbeek, Johannes Berkhof, Peter J.F. Snijders, Chris J.L.M. Meijer	134
8	DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women 2014 ·British Journal of Cancer ·(unknown), (unknown), (unknown), Ed Schuuring, Daniëlle A.M. Heideman, Leon F.A.G. Massuger, Viola M.J. Verhoef, Johan Bulten, Willem J. G. Melchers, Ate G.J. van der Zee, Ruud L.M. Bekkers, G. Bea A. Wisman	52
9	Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women 2014 ·Preventive Medicine ·Remko P. Bosgraaf, (unknown), Viola M.J. Verhoef, Leon F.A.G. Massuger, Chris J.L.M. Meijer, Willem J. G. Melchers, Ruud L.M. Bekkers	71
10	Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer 2014 ·Gynecologic Oncology ·Viola M.J. Verhoef, Daniëlle A.M. Heideman, Folkert J. van Kemenade, Lawrence Rozendaal, Remko P. Bosgraaf, Albertus T. Hesselink, Ruud L.M. Bekkers, Leon F.A.G. Massuger, Renske D.M. Steenbergen, Peter J.F. Snijders, Johannes Berkhof, Chris J.L.M. Meijer	43
11	Comparative performance of novel self‐sampling methods in detecting high‐risk human papillomavirus in 30,130 women not attending cervical screening 2014 ·International Journal of Cancer ·Remko P. Bosgraaf, Viola M.J. Verhoef, Leon F.A.G. Massuger, Albert G. Siebers, Johan Bulten, (unknown), Chris J.M. Meijer, Peter J.F. Snijders, Daniëlle A.M. Heideman, Joanna IntHout, Folkert J. van Kemenade, Willem J. G. Melchers, Ruud L.M. Bekkers	67
12	A second generation cervico-vaginal lavage device shows similar performance as its preceding version with respect to DNA yield and HPV DNA results 2013 ·BMC Women s Health ·Viola M.J. Verhoef, Maaike G. Dijkstra, Remko P. Bosgraaf, Albertus T. Hesselink, Willem J. G. Melchers, Ruud L.M. Bekkers, Johannes Berkhof, Folkert J. van Kemenade	10
13	High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening 2012 ·International Journal of Cancer ·Peter J.F. Snijders, Viola M.J. Verhoef, Marc Arbyn, Gina Ogilvie, Silvia Minozzi, Rita Banzi, Folkert J. van Kemenade, Daniëlle A.M. Heideman, Chris J.L.M. Meijer	211
14	NOX5 Expression Is Increased in Intramyocardial Blood Vessels and Cardiomyocytes after Acute Myocardial Infarction in Humans 2012 ·American Journal Of Pathology ·Nynke E. Hahn, Christof Meischl, Tsukasa Kawahara, René J.P. Musters, Viola M.J. Verhoef, Jolanda van der Velden, Alexander B.A. Vonk, Walter J. Paulus, Albert C. van Rossum, Hans W.M. Niessen, Paul A.J. Krijnen	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact